Autosomal dominant facioscapulohumeral muscular dystrophy (FSHDI has an unusual pathogenic mecha nism. FSHD is caused by deletion of a subset of D4Z4 macrosatellite repeat units in the subtelomere of chro mosome 4q. Recent studies provide compelling evi dence that a retrotransposed gene in the D4Z4 repeat, DUX4, is expressed in the human germline and then epigenetically silenced in somatie tissues. In FSHD, the combination of ineffieient ehromatin sileneing of the D4Z4 repeat and polymorphisms on the FSHD-permis sive alleles that stabilize the DUX4 mRNAs emanating from the repeat result in inappropriate DUX4 protein expression in muscle cells. FSHD is thereby the first example of a human disease eaused by the inefficient repression of a retrogene in a macrosetellite repeat array.
Facioscapulohumeral muscular dystrophy
Facioscapulohumeral dystrophy (FSHD) was first de scribed by two French neurologists in the late nineteenth century [1] . The disease was named after its clinical pre sentation to distinguish it from the well known Duchenne type of muscular dystrophy. Indeed, the core phenotype of FSHD involves progressive weakness and wasting of the facial (facio), shoulder and upper arm (scapuIohumeral) muscles (for a detailed clinicai description, see Box 1). There is currently no treatment available for FSHD (for outstanding questions, see Box 2) [2] .
The major form of FSHD (FSHD1: MlM # 158900) is autosomal dominantly transmitted with linkage to the sub telomere of chromosome 4q [3] . The FSHD1 locus was mapped in 1990 [4] , the first genetic condition to be mapped with polymorphic microsatellite repeats, and the nature of the genetic defect was resolved in 1993 [5] . Nevertheless, its pathogenic mechanism remains somewhat elusive. This review fOClises on recent developments that establishFSHD as the first example of a human disease caused by the inefficient repression of a retrogene array.
FSHD is a repeat disease
FSHD1 is caused by a contraction of the highly polymor phic D4Z4 macrosatellite repeat in chromosome 4q (Box 3, [6] . The D4Z4 macrosatellite repeat is located approximately 40-60 kb proximal to the telomere repeat and varies between Il and >100 copies ofD4Z4 units in the unaffected population [6, 7] . The D4Z4 repeat unit is de fined as a 3.3 kb Kpnl fragment, and multiple units are ordered head-to-tail to form the D4Z4 repeat array. Most patients with FSHD1 have a partial and internal deletion ofthe repeat array leaving only 1-10 units on one oftheir chromosomes 4. It is believed that at least one unit ofD4Z4 is necessary to develop FSHD, as monosomy of4q does not cause FSHD [8] .
A contraction ofthe D4Z4 repeat array only predisposes to the disease; this contraction needs to occur on a specific chromosomal background [9] . Soon af'ter the discovery of the D4Z4 repeat on chromosome 4, it was established that the subtelomere of chromosome 10q is almost identical to that of chromosome 4q and that it also contains a highly homologous and equally polymorphic repeat array [10,111. A considerable proportion of individuals in the population carry 4q or 10q chromosome ends with repeat arrays that have apparently been entirely or partially transferred between both chromosomes [7, 12, 131 . However, contracted repeat arrays on chromosome lO have until recently never been shown to cause FSHD [14, 15] .
The observation of linkage of the disease with chromo some 4 and the absence oflinkage with chromosome lO led to the hypothesis that interplay ofD4Z4 with other, more proximal elements on chromosome 4 could explain the chromosome 4 specificity of the disease. In this scenario, either by spreading [16] or looping [17, 18] mechanisms, the D4Z4 repeat contraction would affect the transcriptional regulation of proximal chromosome 4-specific genes. In deed, closely located genes with high myopathic potential were reported to be transcriptionally upregulated [16] in FSHD, such as FRGl, FRG2 and ANTl. Variability be tween studies possibly owing to biological differences be tween the tissues sampled and technical differences between the various studies, however, prevented a consen sus agreement on any single mechanism [19] .
Homologous is not identica I
The D4Z4 repeat and its homolog are located in the sub telomere of chromosomes 4 and lO. Subtelomeres are un usual domains, showing a relatively high level ofplasticity Box 1. Clinical manifestations of FSHD At disease onset, typically in the second decade of life, FSHD is characterized by initially restricted weakness of shoulder and facial muscles [1, 48] . With progfession, the lower extremities, both distai and proximal, become involved. The spectrum of disease severity is wide, ranging from mildly affected, asymptomatic individuals to severely affeeted wheelchair bound individuals (approx. 20%). Non muscular manifestations include hearing loss and retinal vascular abnormalities that remain largely of no clinical consequence [49, 50] . Rarely, however, the retinal vascular disease can result in an exudative retinopathy, Coat's syndrome, that can result in signifi cant loss of vision. There is no linear and inverse correlation between residual repeat size and disease severity and onset. However, patients having repeat arrays of 1-3 units usually have an infantile onset and rapid progression [51] .
and resulting in the frequent transfer ofsequences between homologous and nonhomologous chromosome ends [201.
To understand the chromosome 4 linkage with the disease, genetic studies were undertaken leading to the identification of the mechanism of D4Z4 rearrangements and to the identification of large polymorphisms in the subtelomere ofchromosome 4q [21- • What is the function of DUX47 DUX4 is highly conserved and robustly expressed in testis, most probably germline. It contains two homeoboxes suggesting that it can bind DNA and can act as a transcription factor. However, its function, and how it confers toxicity to the muscle is as yet poorly understood.
• Can we treat FSHD7 Assuming that leaky expression of DUX4 is causai to FSHD, it is imperative to pursue strategies to interfere with DUX4 expression in muscle with the obiective to ameliorate the disease. These could include RNA interference strategies, ways to silence the DUX4 locus or molecules that neutralize DUX4 toxicity. Approximately half of the human genome consists of repetitive DNA. and a significant proportion is organized in tandem arrays. These tandem arrays of DNA embody an extreme example of copy number variation and are classified according to their repeat unit size and their total length. Although different definitions exist, repeat unit sizes 1--4 nucleotides and spanning less tha'n 100 bp are typically defined as microsatellite repeats. Those with repeat unit sizes between 10 and 40 nucleotides covering severa I hundreds of base pairs are referred to as minisatellite repeats. The term midisatellite repeat has been proposed for loei eontaining repeat units of4O---100 nucleotides that can extend over distances of 250 500 kb. Macrosatellite repeats, to which D4Z4 belongs, are the largest class of repeat arrays with unit sizes of >100 nucleotides but which are typically much larger and can span hundreds of kilobases of DNA. Whereas FSHD represents a macrosatellite repeat contrac tion disease, microsatellite repeat expansions are a frequent cause of neurodegenerative diseases.
are almost equally common in the population, FSHD chromosomes seemed to be exclusively of the 4A type [22] , which was later confirmed in independent studies [24,251. Thus, it was concluded that attributes specific to 4A, presumably polymorphisms, confer permissiveness to the D4Z4 repeat. This led to attention being focused on identifying allele specific polymorphisms associated with FSHD. Initially, a simple sequence length polymorphism was identified im mediately proximal to the D4Z4 repeat and was instru mental in our understanding ofthe genetic basis ofFSHD [9,261. Studies in patients and control individuals from different populations showed that during recent human evolution, there were probably only four events in which sequences were transferred between chromosomes 4 and lO. Subsequent detailed genetic studies ofthe FSHD locus led to the identification of additional polymorphisms sub dividing chromosome 4 into at least 17 genetically distinct subtelomeric variants and chromosome lO into 8 subte lomeric variants. Intriguingly, contractions in only three genetically almost identical chromosome 4 subtelomeres, the common variant 4A161 and the rare variants 4A159 and 4A168, caused FSHD, whereas contractions in other 4q subtelomeres were not associated with disease [9,26-281. This finding provided strong evidence that genetic fac tors in the subtelomere of chromosome 4 contribute to FSHD pathology, and indeed detailed sequence analysis of the first and last repeat unit of the array of the most common chromosomal backgrounds identified 4A161-spe cific sequence variants [26,281. Thus, not only outside the D4Z4 repeat, but also within the repeat array, it was shown that the permissive chromosomes contained specific se quence variants not shared by other (nonpermissive) chro mosome ends [26, 281 . In summary, these detailed genetic studies revealed that each chromosome maintained specif ic polymorphisms and that specific sequences in the FSHD permissive variants of 4A confer permissiveness to this repeat.
The D4Z4 unit and its transcriptional landscape
The sequence ofthe D4Z4 repeat contains the open reading frame (ORF) of a double-homeobox transcription factor, DUX4 (Figure 1) [29, 301 . The DUX4 ORF is in a single exon, whereas other members of the double-homeobox family have multiple introns, indicating that DUX4 was inserted into the genome as a retrotransposed mRNA!rom an intron containing the DUX gene, possibly either DUXC or, less likely, Duxbl [31] [32] [33] . In contrast to the many pseudogenes retrotransposed to our genome, the DUX4 retrogene maintained a conserved ORF [31] . However, it is unclear whether the conservation ofthe ORF was a conse quence of a conserved functional role propagated to alI repeats by concerted evolution. Although initia! attempts to identifY DUX4 mRNA ex pression in norma! development or disease were unsuccess fui [34] , a major advance in understanding FSHD was the identification of polyadenylated mRNA containing the DUX4 ORF using RT-PCR [35] . InitialIy identified only in FSHD muscle samples, the polyadenylation site of the DUX4 mRNA was mapped to the region immediately telo meric to the last D4Z4 repeat, a region previ~usly cloned from a phage clone containingthe D4Z4 repeat and flanking sequences and called pLAMl [51. It was proposed that the contraction ofthe D4Z4 array results in the transcription of the DUX4 retrogene [35] ; however, the abundance of the DUX4 mRNA and protein was extremely low.
In addition, a later study [34] identified D4Z4 and DUX4 transcripts in both FSHD and controi muscle. Random priming of RNA identified both sense and antisense tran scripts throughout the D4Z4 region. Ragions of lower transcript abundance correlated with the presence of siRNA-or miRNA-sized fragments, and it was suggested that these bidirectiona! transcripts and small RNAB con tribute to the heterochromatin suppression of this region [34] (see below). In addition, several splice forms ofa DUX4 polyadenylated mRNA were identified that used the pLAM1 polyadenylation site, but these DUX4 transcripts were also at extremely low abundance [34] . Severa! groups demonstrated that relatively high levels of DUX4 expres sion were pathologic to muscle celIs and other cell types [36] [37] [38] [39] . Therefore, ifDUX4 could be shown to be expressed at sufficient levels in FSHD, then it was likely to be a major cause ofthe muscle pathology.
Chromatin studies A third important clue that could explain how a repeat contraction can cause disease came !rom chromatin studies ofthe D4Z4 array. The D4Z4 repeat is GC-rich and contains sequences often residing in heterochromatic domains ofthe genome [40] . It was therefore postulated that normally the D4Z4 repeat is in a relatively closed chromatin configuration and tOOt, as a consequence of repeat contraction, it would adopt a more open chromatin configuration <Figure 1). DNA methylation studies and studies of histone modifications and other chromatin factors supported this hypothesis [17, 41, 42] . Norma1Iy, the D4Z4 repeat is densely DNA methylated; FSHD chromosomes experience an approxi mate 30-40% reduction ofDNA methylation at specific sites testedin D4Z4. Inaddition, chromatinimmunoprecipitation (ChIP) studies showed that the D4Z4 repeat is norma1Iy occupied by both transcriptiona11y repressive as well as permissive histone modifications, whereas in FSHD chro mosomes, there is a relative Ioss of repressive histone modifications. These changes in chromatin structure are restricted 10 the D4Z4 repeat and do not seem 10 spread proximally. ChIPstudies also identified the Iosses or gains of other chromatin factors such as HPl' Y, the cohesin complex, YV1 (losses) and CTCF (gain) at D4Z4 of disease alleles [16, 42, 431 . Overall, the data support a model in which D4Z4 in FSHD chromosomes adopts a relatively open chromatin structure facilitating the transcriptional activity of the re peat and possibly affecting the processing of the different D4Z4 transcripts.
Interestingly, similar changes in the chromatin struc ture of D4Z4 were also identified in a small cohort of patients whose disease status cou1d not be confirmed by standard molecular diagnostic tests [42, 44, 45] . These patients, now classified as FSHD2, have normaI, but com pared 10 the generaI population, smaller-sized D4Z4 repeat arrays; disease alleles of FSHD2 patients show similar changes in D4Z4 chromatin structure as those of FSHD1 patients [45] . In contrast 10 FSHD1 where the relative relaxation ofthe D4Z4 chromatin structure seems restrict ed 10 the contracted allele, the D4Z4 repeats on both chromosomes 4 and lO seem to be affected in patients with FSHD2. Other repeat structures in the genome of these patients seem 10 be normally structured [46] and the cause for this change in chromatin structure ofD4Z4 in patients with FSHD2 is currently not known. Also in common with FSHD1, patients with FSHD2 have at least one permissive (4A161) chromosome [45] . Thus, it seems that patients with FSHD1 and FSHD2 share the commonality of a relative chromatin relaxation of D4Z4 on the genetic 4A161 background.
A new developmental model for FSHD
Very recently, genetic studies directly demonstrated the requirement of the DUX4 polyadenylation site for FSHD [28] , and molecular studies have produced a new develop mental model for the disease that is consistent with the extremely low abundance of the mRNA and protein [47] (Figure 2) . Together, these studies explain the apparent discrepancies in previous models of FSHD and provide compelling support for the expression ofDUX4 as a major cause ofFSHD. 
TRENDS in Molooular Medicina
Flllure2. A unifying mechanism for FSHO. Upon lal contraetion ofthe D4Z4 repe_t (FSH01) or by (bI a yet unknown mechanism (FSH02), the 04Z4 repeat array (triangles)
adopts _ more open chromatin configuration (or8nge > green dots' leading to the leaky expression of DUX4 mRNA. On permissive chromosomes, thi. mRNA is stabilized owing to the presence of a canonical polyadenylation signal immediately distai to the 04Z4 repeat array. (c) Nonpermissive chromosomes do not have this polyadenylatlon signal and therefore DUX4mRNA becomes rapidly degraded. The DUX4 mRNA encodes for a nuclear double-homeobox proteln thatwhen expressed in muscle induce. apoptosis.
Meticulous genetic analysis of patients with unusual hybrid D4Z4 repeat structures containing units with se quence signatures consistent with those originating from chromosomes 4 and lO revealed a common last portion of the D4Z4 repeat array and Hanking pLAM1 sequence (281. This old-fasmoned positional cloning strategy strongly argued that the distaI end ofthe repeat arrayand Hanking pLAM1 sequences are crocially important for the develop ment ofFSHD (281. Further corroborating tms finding was the identification of a FSHD family in which the disease segregated with a contracted D4Z4 allele of chromosome lO. Importantly, the last part of tms disease-associated repeat array was replaced by permissive chromosome 4 sequences. The identification ofthis family in wmch FSHD segregates with chromosome lO essentially conftrms the importance of the distaI end of the repeat and pLAM1 sequences and precludes a prominent role for other proxi mal candidate genes on chromosome 4.
Further genetic studies of the distal end of the D4Z4 repeat array and Hanking sequences allowed an almost perfect separation of permissive and nonpermissive chro mosome ends based on the identification of consistent polymorpmsms in the region sequenced [281. One notice able difference between permissive chromosomes 4 and nonpermissive chromosomes lO was the presence of a DUX4 polyadenylation signal on chromosome 4, whereas on chromosome lO tms polyadenylation signa! was lost because of the presence of independent polymorpmsms [28] . Indeed, when transfecting the crociaI region in mu rine C2C12 muscle cells, stable DUX4 transcripts making efficient use ofthe DUX4 polyadenylation signal could only be identified when constrocts derived from permissive chromosomes with a polyadenylation signal were trans fected [28] . Interestingly, a study of the recent hominoid evolution ofthe 4q subtelomere shows that the permissive chromosome end is ancestral to all 4q chromosome ends, and the data are consistent with an evolutionary pressure to eliminate the third DUX4 exon in pLAM1 [26] . These genetic studies clearly demonstrated the requirement for the polyadenylation site utilized by DUX4 mRNA and, therefore, strongly implicated DUX4 protein as a cause ofFSHD. However, as noted above, althoughDUX4 mRNA was detected in FSHD muscle, it was stilI at extremely low abundance.
Low abundance mRNA in a population of cells could reHect either a small amount of mRNA in aH cells or an abundant amount of mRNA in just a few cells. RT-PCR amplification of DUX4 mRNA in small pools of 100 or 600 differentiated FSHD muscle cells identified relatively abundant transcripts in a subset of the pools [47] . The frequency ofpositive pools suggested that approximately 1 in 1000 FSHD musc1e cell nuclei were expressing an abundant amount of DUX4 mRNA. Immunodetection con firmed that approximately 0.1 % ofnuclei in cultured FSHD muscle cells expressed an abundant amount of protein. In addition, the DUX4-expressing FSHD muscle nuclei had characteristics consistent with DUX4 induced toxicity, i.e. an aggregation of nuclear DUX4 protein that occurs coin cident with DUX4-induced apoptosis. Therefore, the very low abundance of DUX4 mRNA in FSHD muscle repre sented relatively abundant amounts of DUX4 mRNA and AB aretrogene, DUX4 was viewed by some as a dead gene, or pseudogene, brought 'back to life' by the contraction of the D4Z4 array, but the conservation of the ORF suggested otherwise [32] [33] [34] . Indeed, DUX4 mRNA and protein was shown to be highly expressed in the testes of unaffected individuals, most probably in the germline, both from the permissive 4A161 allele as well as from the nonpermissive alleles [47] . I t is interesting to note that the germline D UX4 mRNA transcripts from chromosome lO, wmch lacks the polyadenylation site that is present on the permissive chro mosomes, use an alternative polyadenylation site approxi mately 6 kb telomeric to the end ofthe D4Z4 array. Use of tms alternative polyadenylation was restricted to germline tissues and not identified in somatic tissues [47] . Therefore, the DUX4 retrogene is expressed in early development, i.e. in the human germline, and is epigenetically silenced in somatic tissues. The inefficient chromatin-mediated repres sion, either related to the contraction ofthe array in FSHD1 or through unknown mechanisms in FSHD2, results in the occasionaI escape from repression in muscle cells, and pos sibly other somatic cells. In tms model, the muscle cell nuclei would be lost over time in FSHD because of the inappropri ate expression of DUX4 protein (Figure 2 ).
Concluding remarks
These recent studies substantiate a developmental model ofFSHD that explains many ofthe previously unexplained mysteries of this human disease. First, genetic studies demonstrate the requirement for the DUX4 polyadenyla tion site in the pLAM1 region of the permissive alleles, indicating that DUX4 mRNA is crocial for FSHD [28] . Second, molecular studies show decreased density of re pressive chromatin modifications in both FSHD1 and FSHD2 [61, indicating that DUX4 mRNA is more likely to be expressed. Third, RNA and protein studies showed an occasional es cape from the inefficient chromatin repression leadiug to high levels of DUX4 expression in a small number of nuclei in FSHD muscle cells [471. Fourth, abun dant expression of DUX4 in testis, most probably the germline cells, indicates that tms retrogene might have a normal role in germ cell development [471. Finally, if a retrogene has subsumed a normal role in germ ceH biology, then repression ofthat gene in somatic cells needs to co-opt regulatory mechanisms distinct from the evolved enhan cers and promoters of the parental gene. Therefore, the repression of DUX4 in somatic cells is probably a mecha nism adopted from other loci, such as the mechanism of silencing retrotransposons and other repetitive elements, and is not highly evolved for the DUX4 locus. In this case, co-opted mechanisms might not be sufficiently robust to avoid disease, as is evident by the association of FSHD with the contracted D4Z4 array.
This new unifYing and substantiated model of FSHD has one additional profound and as yet unexplored impli cation. DUX4 arose from the retrotransposition ofa paren talDUXmRNA, possibly either DUXC or, less likely, Duxbl [31-331. BothDUXC andDuxbl are expressed in the germ line, a requirement for introducing a retrogene into the population, but neither is present in primates [33] . There fore, primates have retained the retrogene and Iost the parental gene, suggesting a selective advantage of the retrogene. Primates have sacrificed upper extremity and faciai muscle mass for the advantage of an upright posture and highly expressive faciaI muscles. Although this remains highly speculative, it is interesting to suggest that the DUX4 retrogene might have been retained in preference to the parental gene because inefficient ebro matin repression resuIts in sufficient expression in skeletal muscle to modulate facial and upper extremity muscle mass, even in individuaIs without the FSHD deletion. If this is correct, then FSHD is a hypermorphie phenotype for traits that are crociai for primate evolution, and the mys tery of FSHD still has the potentiaI to lead us to new understandings ofhuman biology.
